149
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Evaluating the efficacy of short duration Mitomycin C in safe surgery system trabeculectomy combined with cataract surgery

, , &
Pages 849-857 | Published online: 22 May 2019

References

  • Odberg T. Visual field prognosis in advanced glaucoma. Acta Ophthalmol. 1987;65:27–29. doi:10.1111/j.1755-3768.1987.tb02583.x
  • Mikelberg FS, Schulzer M, Drance SM, Lau W. The rate of progression of scotomas in glaucoma. Am J Ophthalmol. 1986;101:1–6.
  • Grant WM, Burke JF Jr. Why do some people go blind from glaucoma? Ophthalmology. 1982;89:991–998.
  • Giuffrè I, Taverniti L, Di Staso S. The effects of 2% ibopamine eye drops on the intraocular pressure and pupil motility of patients with open-angle glaucoma. Eur J Ophthalmol. 2004;14:508–513.
  • Virno M, Sampaolesi R, Pecori Giraldi J, et al. Ibopamine: D1-dopaminergic agonist in the diagnosis of glaucoma. J Glaucoma. 2013;22:5–9. doi:10.1097/IJG.0b013e3182311db4
  • Mastropasqua R, Agnifili L, Fasanella V, et al. The conjunctiva-associated lymphoid tissue in chronic ocular surface diseases. Microsc Microanal. 2017;23:697–707. doi:10.1017/S1431927617000538
  • Wilkins M, Indar A, Wormald R. Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev. 2005;4:CD002897.
  • Chen CW, Huang HT, Bair JS, Lee CC. Trabeculectomy with simultaneous topical application of mitomycin C in refractory glaucoma. J Ocul Pharmacol. 1990;6:175–182.
  • Rotham RF, Liebmann JM, Ritch R. Low dose 5-fluorouracil trabeculectomy as initial surgery in uncomplicated glaucoma: long-term follow up. Ophthalmology. 2000;107:1184–1190.
  • Mastropasqua R, Fasanella V, Brescia L, et al. In vivo confocal imaging of the conjunctiva as a predictive tool for the glaucoma filtration surgery outcome. Invest Ophthalmol Vis Sci. 2017;58:BIO114–BIO120. doi:10.1167/iovs.17-21795
  • DI Staso S, Agnifili L, DI Gregorio A, et al. Three-dimensional laser scanning confocal analysis of conjunctival microcysts in glaucomatous patients before and after trabeculectomy. In Vivo. 2017;31:1081–1088. doi:10.21873/invivo.11173
  • Jampel HD, Solus JF, Tracey PA, et al. Outcomes and bleb-related complications of trabeculectomy. Ophthalmology. 2012;119:712–722. doi:10.1016/j.ophtha.2011.09.049
  • Friedman DS, Jampel HD, Lubomski LH, et al. Surgical strategies for coexisting glaucoma and cataract. Ophthalmology. 2002;109:1902–1913.
  • Mittal S, Mittal A, Ramakrishnan R. Safety and efficacy of manual small-incision cataract surgery combined with trabeculectomy: comparison with phacotrabeculectomy. Asian J Ophthalmol. 2008;10:221–229.
  • Bowman RJ, Hay A, Wood ML, Murdoch IE. Combined cataract and trabeculectomy surgery for advanced glaucoma in East Africa: visual and intraocular pressure outcomes. Eye. 2010;24:573–577. doi:10.1038/eye.2010.7
  • Thomas R, Paul P, Muliyil J. Glaucoma in India. J Glaucoma. 2003;12:81–87. doi:10.1097/00061198-200302000-00016
  • Edmunds B, Thompson JR, Salmon JF, Wormald RP. The National Survey of Trabeculectomy. III. Early and late complications. Eye (Lond). 2002;16:297–303. doi:10.1038/sj/eye/6700148
  • Anand N, Arora S, Clowes M. Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. Br J Ophthalmol. 2006;90:175–180. doi:10.1136/bjo.2005.077800
  • Khaw PT, Chiang M, Shah P, Sii F, Lockwood A, Khalili A. Enhanced trabeculectomy: the Moorfields safer surgery system. Dev Ophthalmol. 2012;50:1–28.
  • Al Habash A, Aljasim LA, Owaidhah O, Edward DP. A review of the efficacy of mitomycin C in glaucoma filtration surgery. Clin Ophthalmol. 2015;9:1945–1951.
  • Jampel HD. Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon‘s capsule fibroblasts. Ophthalmology. 1992;99:1471–1476.
  • Md G, Glovinsky Y. Trabeculectomy with brief exposure to mitomycin C. Clin Exp Ophthalmol. 2006;34:765–770. doi:10.1111/j.1442-9071.2006.01305.x
  • Sihota R, Angmo D, Chandra A, Gupta V, Sharma A, Pandey RM. Evaluating the long-term efficacy of short-duration 0.1 mg/ml and 0.2 mg/ml MMC in primary trabeculectomy for primary adult glaucoma. Graefes Arch Clin Exp Ophthalmol. 2015;253:1153–1159. doi:10.1007/s00417-015-3028-9
  • Khandelwal RR, Raje D, Rathi A, Agashe A, Majumdar M, Khandelwal R. Surgical outcome of safe surgery system trabeculectomy combined with cataract extraction. Eye. 2015;29:363–370. doi:10.1038/eye.2014.294
  • Lee SJ, Paranhos A, Shields MB. Does titration of mitomycin C as an adjunct to trabeculectomy significantly influence the intraocular pressure outcome? Clin Ophthalmol. 2009;3:81–87.
  • Mégevand GS, Salmon JF, Scholtz RP, Murray AD. The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. Ophthalmology. 1995;102:84–90.
  • Kim YY, Sexton RM, Shin DH, et al. Outcomes of primary phakic trabeculectomies without versus with 0.5- to 1 min versus 3- to 5 min mitomycin C. Am J Ophthalmol. 1998;126:755–762.
  • Alwitry A, Abedin A, Patel V, Moodie J, Rotchford A, King A. Primary low-risk trabeculectomy augmented with low-dose mitomycin-C. Eur J Ophthalmol. 2018;19:971–976. doi:10.1177/112067210901900612
  • Annen DJ, Stürmer J. Follow-up of a pilot study of trabeculectomy with low dosage mitomycin C (0.2 mg/ml for 1 min). Independent evaluation of a retrospective nonrandomized study. Klin Monbl Augenheilkd. 1995;206:300–302. doi:10.1055/s-2008-1035446